After performing validation in both TCGA dataset and GEO dataset GSE17679, we extracted a group of immune-related genes, including NR1H3, VAMP5, GIMAP2, GBP2, HLA-E and CRIP1 that were most significant to predict good outcomes in sarcoma patients. This evidence concerns the gene GIMAP2 and sarcoma.